Evidence map›Paper›PMID 30249008›Full record

ReviewCells2018

Multifaceted Interweaving Between Extracellular Matrix, Insulin Resistance, and Skeletal Muscle.

Khurshid Ahmad, Eun Ju Lee, Jun Sung Moon, So-Young Park, Inho Choi

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Effect ofHeliyon · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Biophysics reviews · 2022
    Review
  18. MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators.International journal of molecular sciences · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Khurshid AhmadDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea. ahmadkhursheed2008@gmail.com.ORCID 0000-0002-1095-8445
Eun Ju LeeDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea. gorapadoc0315@ynu.ac.kr.
Jun Sung MoonDepartment of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Korea. mjs7912@yu.ac.kr.
So-Young ParkDepartment of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Korea. sypark@med.yu.ac.kr.
Inho ChoiDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea. inhochoi@ynu.ac.kr.
Yeungnam University · KR

Funding

Creative Economy Leading Technology Development Program of the Gyeongsanbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea #SF316001ANext-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea. PJ01324701
6 · The paper itself

Abstract

The skeletal muscle provides movement and support to the skeleton, controls body temperature, and regulates the glucose level within the body. This is the core tissue of insulin-mediated glucose uptake via glucose transporter type 4 (GLUT4). The extracellular matrix (ECM) provides integrity and biochemical signals and plays an important role in myogenesis. In addition, it undergoes remodeling upon injury and/or repair, which is also related to insulin resistance (IR), a major cause of type 2 diabetes (T2DM). Altered signaling of integrin and ECM remodeling in diet-induced obesity is associated with IR. This review highlights the interweaving relationship between the ECM, IR, and skeletal muscle. In addition, the importance of the ECM in muscle integrity as well as cellular functions is explored. IR and skeletal muscle ECM remodeling has been discussed in clinical and nonclinical aspects. Furthermore, this review considers the role of ECM glycation and its effects on skeletal muscle homeostasis, concentrating on advanced glycation end products (AGEs) as an important risk factor for the development of IR. Understanding this complex interplay between the ECM, muscle, and IR may improve knowledge and help develop new ideas for novel therapeutics for several IR-associated myopathies and diabetes.

Indexed as

advanced glycation end productsextracellular matrixinsulin resistanceskeletal muscle

Identifiers

PMID30249008
PMCPMC6211053
OpenAlexW2892297188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.